NCT05691491 2026-03-18Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and EffectivenessNational Cancer Institute (NCI)Phase 1/2 Recruiting58 enrolled
NCT03519412 2026-03-03ARETHUSAIFOM ETS - The AIRC Institute of Molecular OncologyPhase 2 Completed107 enrolled 14 charts